Projects funded by the NCN
Analysis of semaphorin 3 (SEMA3), protocadherin 9 (PCDH9) and S 100 calcium binding proteinA3 (S100A3) expression in progression of ovarian cancer and resistance to cytotoxic drugs
2021/41/B/NZ5/01128
Keywords:
ovarian cancer cancer progression chemoresistance
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_5: Diagnostics in human diseases
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Zielonogórski, Collegium Medicum
woj.
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 2 338 460 PLN
Project start date (Y-m-d): 2022-01-21
Project end date (Y-m-d): 2027-01-20
Project duration:: 60 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (2)
- The TGFBI gene and protein expression in topotecan resistant ovarian cancer cell linesAuthors:Karolina Wojtowicz, Monika Swierczewska, Michał Nowicki, Radosław JanuchowskiAcademic press:Advances in Medical Sciences (rok: 2023, tom: 68, strony: 379–385), Wydawca: ELSEVIERStatus:PublishedDOI:10.1016/j.advms.2023.09.013 - link to the publication
- The response and resistance to drugs in ovarian cancer cell lines in 2D monolayers and 3D spheroidsAuthors:Monika Świerczewska, Karolina Sterzyńska, Marcin Rucisnski, Małgorzata Andrzejewska, Michał Nowicki, Radosław JanuchowskiAcademic press:Biomedicine & Pharmacotherapy (rok: 2023, tom: 165, strony: 115152), Wydawca: ELSEVIERStatus:PublishedDOI:10.1016/j.biopha.2023.115152 - link to the publication